Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array solutions to fuel genomic discoveries
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
France Science International Affairs | Other 2 Jan 2025 | | ||
Standard BioTools Biotechnology Research, biotech, deeptech | Other 13 Jan 2025 | | ||
Cambridge Sustainable Food CIC greentech, Non-profit Organizations, cleantech, foodtech | Other 13 Dec 2024 | | ||
Pixelgen Technologies biotech, deeptech | Other 10 Dec 2024 | | ||
CHU Dijon Bourgogne Hospitals and Health Care | Other 31 Oct 2024 | | ||
Asia Pacific Medical Technology Association (APACMed) Medical Equipment Manufacturing, healthtech, deeptech | Other 24 Nov 2024 | | ||
Big4Bio Book and Periodical Publishing | Other 19 Nov 2024 | | ||
Public Policy Projects Government Administration | Other 15 Nov 2024 | | ||
AgiLab IT Services and IT Consulting, it services | Other 6 Nov 2024 | | ||
New York State Department of Health Wellness and Fitness Services | Other 30 Oct 2024 | |